ARCHIVES

As Bristol’s Final Defenses Fall, IVAX Prepares Launch Of Generic Paclitaxel.

This article is from The Cancer Letter archive.

Vol. 26 No. 38 | October 20, 2000

Download PDF Visit The Full Archive

Related Articles

NCI Official Says Public Health Issue As Important As Data In Mammography

April 2, 1993

NIH Reauthorization Threatened By Fetal Research Issue

October 5, 1990

In Brief: Panel Meeting Canceled; New Senior Executive Service Draws Enthusiastic Response At NCI

July 13, 1979

Commemoration Planned For Heidelberger

February 11, 1983

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

December 5, 2014

Cancer Advocacy: March On Washington Scheduled For September 1998

October 31, 1997